COYA 302

Drug identity checked against registry records

Also recorded as LD rhIL-2 and CTLA-4 Ig

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of COYA 302 for the Treatment of ALSNCT07161999Coya TherapeuticsPhase 2, Phase 3Active not recruiting2027-04Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.